Lottery Incentive Nudges to Increase Influenza Vaccinations

NCT05012163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57581

Last updated 2024-12-30

Study results available
· View outcomes & findings →

Summary

In the current study, the study team will explore whether small incentives are effective at promoting flu vaccine uptake. The study is designed to compare the relative efficacy of incentives of equal perceived expected value (EV) or equal implementation costs, to assess whether people are more likely to get vaccinated in response to lotteries with very high payoffs than to small certain cash payout or slightly higher-probability, more moderate payoffs. In particular, given the potential appeal of official state lottery tickets, one study arm will receive a Pennsylvania scratch-off lottery ticket for getting a flu vaccine. A primary hypothesis is that lotteries will outperform simple reminders (encouraging respondents to get the flu shot at their upcoming appointment) and the standard of care, representing the ambient healthcare system and public health campaigns to increase vaccination.

Conditions

  • Influenza
  • Vaccination
  • Health Promotion
  • Health Behavior

Interventions

BEHAVIORAL

Reminder

Letter, short message service (SMS) text, phone, and/or email

BEHAVIORAL

Financial incentive

Letter, SMS, phone, and/or email

BEHAVIORAL

Lottery

Letter, SMS, phone, and/or email

Sponsors & Collaborators

  • Geisinger Clinic

    collaborator OTHER
  • Massachusetts Institute of Technology

    collaborator OTHER
  • National Institute on Aging (NIA)

    collaborator NIH
  • National Bureau of Economic Research, Inc.

    lead OTHER

Principal Investigators

  • Michelle N Meyer, PhD JD · Geisinger Clinic

  • Christopher F Chabris, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-04
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05012163 on ClinicalTrials.gov